YSG Q4 2025: Skincare Brands Drive 52% Growth, Margin Expansion in Focus
YSG delivered a decisive pivot toward skincare-led growth, outpacing China’s beauty retail market and restoring profitability. The company’s R&D-driven innovation cycle, channel optimization, and disciplined cost management underpinned robust margin recovery and a return to non-GAAP net income. With management guiding for double-digit top-line expansion, investors should watch for further margin leverage as the product mix continues to shift toward premium skincare.
Summary
- Skincare Mix Shift: YSG’s portfolio transformation accelerated, with skincare now over 60% of Q4 revenue.
- Margin Rebound: Operational discipline and high-margin products reversed last year’s losses.
- R&D as Growth Engine: Innovation and premiumization remain central to YSG’s forward strategy.
Performance Analysis
YSG’s Q4 results marked a clear inflection in both revenue and profitability, as the company capitalized on China’s beauty sector rebound and a decisive internal shift toward skincare. Total net revenue rose 20.1% year-over-year, outpacing the broader market’s 8.2% growth in beauty retail sales. This outperformance was anchored by a 51.9% jump in skincare brand revenue, which now accounts for 61.1% of the total versus 53% a year ago. Color cosmetics, by contrast, declined 9.1%, underscoring the deliberate migration to higher-margin categories.
Gross margin remained robust at 77.7%, essentially flat year-over-year, but the real operational story was in expense leverage. YSG slashed total operating expenses by 15.6%, bringing OpEx down to 78.6% of revenue from 111.8% last year. While selling and marketing costs climbed as a share of revenue due to competitive festival periods, reductions in G&A and the absence of goodwill impairment drove a dramatic narrowing of operating losses. The company posted a small GAAP net profit and a positive non-GAAP net income margin, reversing a deep loss in the prior year period.
- Product Mix Evolution: Skincare’s rise is not just top-line accretive, but also lifts blended margin and customer lifetime value.
- Expense Control: G&A and impairment savings offset higher marketing spend, enabling margin recovery.
- Cash Flow Watchpoint: Despite profit gains, net cash from operations turned negative in Q4, requiring monitoring as growth scales.
YSG’s full-year figures reinforce the turnaround: 26.7% revenue growth, a 2.2% net loss margin (down from 20.9%), and a swing to non-GAAP net income. The company’s ability to sustain high gross margins while scaling R&D and optimizing marketing spend will be critical as competition intensifies in China’s beauty market.
Executive Commentary
"Our total net revenue grew by 20.1% year-over-year for the fourth quarter, performing in line with our previous guidance and significantly outpacing the industry average. More importantly, this growth was driven by our skincare brands, which accounted for 61.1% of our total net revenues in the fourth quarter."
Jingfeng Huang, Founder, Chairman and CEO
"I think this year we're going to continue to grow our skincare business much faster than our color cosmetics business. And with skincare business, the gross margin, net margin, are typically much higher than color cosmetics brands. So by doing that, we're going to be able to improve our margin profile."
Dong Haoyang, Chief Financial Officer and Director
Strategic Positioning
1. Skincare-Centric Portfolio Shift
YSG has reoriented its business model around skincare, which now dominates both revenue and growth. Skincare brands, such as Dr. Wu and Galanic, are positioned as innovation leaders, leveraging clinical and premium positioning to capture higher-margin customer segments. This shift is strategic, as skincare not only commands better margins but also drives higher repeat purchase rates and customer loyalty.
2. R&D-Led Product Innovation
Investment in research and development is central to YSG’s competitive edge. The company highlighted proprietary ingredient development, AI-enabled molecular design, and collaboration with external partners as key enablers. The successful launches of Galanic’s VB Serum and CO2 Revelation Cream, both incorporating patented technology, demonstrate the ability to deliver differentiated products that win industry recognition and drive incremental sales.
3. Brand Equity and Premiumization
YSG’s multi-brand strategy spans mass to premium, enabling it to address diverse consumer segments and channel preferences. The company’s ability to build and sustain brand equity is illustrated by Dr. Wu’s clinical positioning and Douyin recognition, as well as Galanic’s award-winning product launches. This breadth provides a hedge against channel volatility and competitive pricing pressure, while premiumization supports margin expansion.
4. Operational Efficiency and Cost Discipline
Cost management is a core pillar of the turnaround. YSG drove down G&A and eliminated impairment charges, while also optimizing supply chain and channel marketing spend. As topline growth returns, management expects further operating leverage, particularly as fixed costs are absorbed by a larger revenue base. The company’s focus on ROI-driven marketing and workflow automation is intended to sustain margin gains even as competition intensifies.
5. Channel and Customer Mix Optimization
YSG is actively optimizing its channel mix, prioritizing platforms and campaigns with higher return on investment. This includes leveraging data-driven CRM and shifting spend toward digital channels that offer better conversion and efficiency. The strategy aims to both maximize immediate sales and increase customer lifetime value by encouraging broader adoption of multi-product skincare regimens.
Key Considerations
YSG’s Q4 demonstrates a business in the midst of a strategic transformation, with the company making deliberate choices to prioritize innovation, margin, and long-term brand value over short-term volume in lower-margin categories.
Key Considerations:
- Innovation Pipeline Vitality: Sustained R&D investment is delivering new products that differentiate YSG’s brands and support price premiumization.
- Competitive Intensity During Festivals: Higher marketing spend during shopping festivals is necessary to maintain share, but could pressure margins if not offset by mix and efficiency gains.
- Cash Flow Caution: Despite margin recovery, negative operating cash flow in Q4 signals the need for continued working capital discipline as growth accelerates.
- Brand Diversification: A multi-brand approach provides resilience, but requires disciplined portfolio management to avoid dilution and maintain focus on high-return segments.
Risks
YSG faces ongoing risks from intensified competition, particularly in digital channels and during major shopping festivals, which can drive up customer acquisition costs and compress margins. Macroeconomic volatility in China and evolving consumer preferences could impact discretionary spending and category growth. The company’s reliance on continued R&D success introduces execution risk, while negative operating cash flow in Q4 underscores the importance of working capital management as the business scales.
Forward Outlook
For Q1 2026, YSG guided to:
- Total net revenue between RMB 958.6 million and RMB 1.08 billion (15% to 30% YoY growth)
For full-year 2026, management did not provide formal guidance, but emphasized:
- Continued outperformance in skincare versus color cosmetics
- Further margin improvement driven by mix shift and operational leverage
Management highlighted several factors that will shape 2026:
- R&D-driven product launches in premium skincare to sustain top-line momentum
- Disciplined marketing and channel optimization to protect margins
Takeaways
YSG’s return to profitable growth is anchored in a deliberate pivot to high-margin skincare, underpinned by innovation and operational discipline. Investors should monitor the company’s ability to sustain R&D-driven product cycles, manage cash flow, and maintain brand equity as competition intensifies.
- Mix Shift Drives Recovery: Skincare’s rapid growth and margin profile were central to the turnaround, providing both top-line and bottom-line leverage.
- Operational Leverage Emerging: Cost discipline and scale are translating into improved profitability, but cash flow sustainability remains a key watchpoint.
- Outlook Hinges on Innovation: Continued R&D execution and successful new launches will be critical to sustain momentum and defend share in a crowded market.
Conclusion
YSG’s Q4 and full-year results reflect a business successfully executing a strategic realignment toward premium skincare and operational efficiency. While the margin and revenue recovery are clear positives, investors should track cash flow trends and the company’s ability to maintain innovation leadership as competition and acquisition costs rise.
Industry Read-Through
YSG’s performance signals a broader pivot in China’s beauty sector, with premium skincare outpacing color cosmetics and R&D-driven innovation becoming a key differentiator. The company’s margin recovery and product mix evolution provide a template for peers seeking profitable growth in a competitive, promotion-heavy market. The sector’s reliance on festival-driven sales and digital channel efficiency will remain central themes, with operational discipline and brand equity investment increasingly separating winners from laggards.